文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

遗传性脂肪营养不良患者的骨表型:系统综述

Bone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本文系统检索PubMed、EMBASE和Cochrane Library,纳入15项报告遗传性脂肪营养不良患者骨相关结局的研究。先天性全身性脂肪营养不良1型和2型可见骨溶解性病变、骨囊肿、骨硬化及假性骨斑点症,小梁部位骨密度正常至偏高;家族性部分性脂肪营养不良2型则表现为皮质部位骨密度降低及小梁骨评分下降。

要点

  • 先天性全身性脂肪营养不良1型和2型以骨溶解性病变、骨囊肿、骨硬化及假性骨斑点症为主
  • 先天性全身性脂肪营养不良患者小梁部位骨密度正常至偏高
  • 家族性部分性脂肪营养不良2型皮质部位骨密度降低、小梁骨评分下降,提示骨质量受损

核心结论

  • 骨异常是遗传性脂肪营养不良的特征性但常被低估的表现,尤其见于先天性全身性脂肪营养不良1型和2型。
  • 现有证据强调脂肪功能障碍对骨骼的广泛影响,需开展标准化、按基因分层的研究以明确骨风险并指导临床管理。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Cochrane Library,未限制发表时间、语言或研究设计。
  • 共识别2632项研究,15项符合纳入标准,多数聚焦先天性全身性脂肪营养不良1型和2型,未发现3型和4型的研究。
  • 研究质量依据PRISMA指南和JBI清单评估。

主要发现

  • 先天性全身性脂肪营养不良1型和2型报告的骨异常包括骨溶解性病变、骨囊肿、骨硬化和假性骨斑点症,主要见于长骨。
  • 先天性全身性脂肪营养不良患者小梁部位骨密度总体正常至偏高。
  • 家族性部分性脂肪营养不良2型以皮质部位骨密度降低和小梁骨评分降低为特征,提示骨质量受损。
  • 提出的机制包括骨髓脂肪组织减少、骨髓脂肪转化紊乱及内分泌信号改变。

临床怎么用

  • 对遗传性脂肪营养不良患者应关注骨骼受累,尤其是先天性全身性脂肪营养不良1型和2型。
  • 评估骨健康时需结合骨密度部位差异,家族性部分性脂肪营养不良2型应关注皮质骨与小梁骨质量。

局限性

  • 纳入研究数量有限(15项),且多集中于先天性全身性脂肪营养不良1型和2型。
  • 缺乏先天性全身性脂肪营养不良3型和4型的骨相关研究数据。
  • 现有证据以描述性为主,需标准化、按基因分层的研究进一步明确骨风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Congenital lipodystrophies (LDs), including congenital generalized LD (CGL) and familial partial LD (FPLD), are rare disorders characterized by absent or abnormal adipose tissue distribution, leading to clinical, hormonal, and metabolic complications. Although these systemic features are well described, data on bone involvement are limited. This literature review summarizes current evidence on bone manifestations in genetic LDs and potential underlying mechanisms. METHODS: A systematic search was performed in PubMed, EMBASE, and the Cochrane Library using terms related to LD and bone outcomes. No restrictions on date, language, or study design were applied. Studies reporting bone-related outcomes in genetic LD in humans were included. Study quality was assessed using PRISMA guidelines and the JBI checklist. RESULTS: Of 2632 studies identified, 15 met the inclusion criteria. Most focused on CGL1 and CGL2; no studies were found on CGL3 or CGL4. Reported bone abnormalities in CGL1 and CGL2 included osteolytic lesions, bone cysts, osteosclerosis, and pseudo-osteopoikilosis, predominantly in long bones. Bone mineral density (BMD) was generally normal to high at trabecular sites. In contrast, FPLD2 was characterized by reduced BMD at cortical sites and lower trabecular bone score, suggesting impaired bone quality. Proposed mechanisms include reduced bone marrow adipose tissue, disrupted marrow fat conversion, and altered endocrine signaling. CONCLUSION: Bone abnormalities are characteristic yet often underrecognized features of genetic LDs, particularly CGL1 and CGL2. Current evidence underlines the broad skeletal impact of adipose dysfunction and highlights the need for standardized, genetically stratified studies to clarify bone risk and guide clinical management in congenital LD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kusgozoglu E, Barge-Schaapveld DQCM, Rensen PCN, et al. Bone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature. J Clin Endocrinol Metab. 2026. PMID: 42402919. doi:10.1210/clinem/dgag256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。